FOXO FOXO TECHNOLOGIES INC.
Services-Commercial Physical & Biological Research · OTC · SEC CIK 1812360 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY44.5%
TTM net income YoY73.2%
TTM EPS YoY—
Revenue 3-yr CAGR261.0%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin7.4%
Net margin-12.3%
FCF margin-0.1%
EBITDA margin10.5%
Returns
ROE-25.9%
ROA-5.5%
ROIC (approx.)12.6%
Asset turnover0.45x
Leverage & solvency
Liabilities / assets100.0%
Debt / equity0.00x
Current ratio0.10x
Interest coverage0.37x
Cash quality & payout
Operating cash flow / net income-0.00x
Accruals ratio-5.5%
Payout ratio—
Capex / revenue0.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $16.37M | $4.05M | $145,291 | $511,000 | $120,000 |
| Cost of revenue | — | — | $132,000 | $344,000 | $120,000 |
| Gross profit | — | — | $13,000 | $167,000 | $120,000 |
| R&D expense | $182,498 | $312,267 | $900,431 | $3.05M | $4.88M |
| SG&A expense | $11.36M | $7.23M | $19.40M | $25.83M | $10.27M |
| Operating income | -$10.33M | -$7.76M | -$22.19M | -$40.17M | -$15.03M |
| Interest expense | $3.43M | $3.91M | $1.06M | $1.44M | $1.12M |
| Pretax income | -$12.63M | -$12.42M | -$26.45M | -$95.25M | -$38.49M |
| Income tax | -$182,831 | — | — | — | — |
| Net income | -$12.43M | -$12.41M | -$26.45M | -$95.25M | -$38.49M |
| EBITDA | -$9.73M | -$6.53M | -$20.91M | -$38.68M | -$14.93M |
| EPS (diluted) | — | — | — | — | — |
| Balance sheet | |||||
| Cash & equivalents | $207,453 | $68,268 | $38,116 | $5.52M | $6.86M |
| Receivables | $2.47M | $2.27M | — | — | — |
| Inventory | $183,627 | $161,466 | — | $1.31M | $295,000 |
| Current assets | $3.11M | $2.88M | $233,729 | $12.30M | $7.62M |
| PP&E, net | $322,357 | $364,481 | $13,641 | — | $187,000 |
| Goodwill | $27.82M | $25.46M | — | — | — |
| Intangibles | $9.77M | $9.02M | $378,283 | $2.04M | $191,000 |
| Total assets | $44.58M | $41.71M | $725,653 | $35.41M | $30.30M |
| Current liabilities | $28.66M | $31.20M | $14.34M | $6.91M | $36.06M |
| Total liabilities | $33.50M | $36.44M | $14.83M | $28.70M | $55.52M |
| Shareholders' equity | $11.14M | $5.32M | -$14.10M | $6.71M | -$25.22M |
| Cash flow statement | |||||
| Operating cash flow | -$3.87M | -$2.84M | -$6.65M | -$23.76M | -$15.05M |
| Capital expenditure | $62,021 | — | — | $110,000 | $118,000 |
| Free cash flow | -$3.93M | — | — | -$23.87M | -$15.17M |
| Investing cash flow | -$655,606 | $13,329 | — | -$1.87M | -$355,000 |
| Financing cash flow | $4.66M | $2.86M | $1.17M | $24.29M | $14.14M |
| Depreciation & amortization | $597,433 | $1.24M | $1.28M | $1.49M | $98,000 |
| Stock-based compensation | -$164,209 | -$101,734 | $381,378 | $11.04M | $131,000 |
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.